Authors: Cure, H Souteyrand, P Ouabdesselam, R Roche, H Ravaud, A D'incan, M Viens, P Fargeot, P Lentz, MA Fumoleau, P Hanauske, A Chollet, P

Citation: H. Cure et al., Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group, MELANOMA RE, 9(6), 1999, pp. 607-610